Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on...
-
PHILADELPHIA, March 09, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...
-
Full year revenue of $400.4 million, recurring revenue growth of 29%Full year organic revenue growth of 24% (1)Net income of $35.5 million with Adjusted EBITDA of $61.1 million (1)2026 Revenue...
-
Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR exon 20 insertion mutant NSCLC expected mid-2026Global pivotal Phase 3 first-line PACC mutant NSCLC study for firmonertinib...
-
PHILADELPHIA, March 05, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...
-
FemTech Market to grow USD 296.85 Bn by 2035, driven by smartphone adoption, rising women’s health awareness, and strong VC funding.
-
PHILADELPHIA, March 03, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...
-
Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Two-wheeler Intelligence and Industry Chain Research Report, 2025-2026" report has been added to ResearchAndMarkets.com's offering.Two-Wheeler...
-
Kosmos Energy 4Q25 Earnings
-
Houston, Feb. 25, 2026 (GLOBE NEWSWIRE) -- As global manufacturing shifts across regions, supply chains, and regulatory environments, execution risk has quietly become one of the biggest constraints...